Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomic landscape in Thailand: Array-based profiling and EMR-linked medication exposure.

PloS one - 1 Jan 2026

Pasookhush Phongthana, Suta Sophida, Pumeiam Sureeporn, Mongkolsucharitkul Pichanun, Pinsawas Bonggochpass, Ophakas Suphawan, Mayurasakorn Korapat

Abstract excerpt

Pharmacogenomic (PGx) data in Thailand remain limited, and genetics-only surveys rarely quantify "realized actionability"-the overlap between actionable PGx phenotypes and real-world medication exposure. We profiled 4,662 Thai adults using SNP-array data and a pre-specified PGx panel (11 genes; 26 markers) with a hybrid required/optional calling policy for diplotype/phenotype assignment. CPIC level A/B gene-drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Electronic Health Records

Share to CYP3A5 gene

Share to Pharmacogenetics

Share to Phenotype

Share to Polymorphism, Single Nucleotide

Share to Thailand

Source

Open in PubMed Open full text

Identifiers

PMID: 42545959
DOI: 10.1371/journal.pone.0355201
PMCID: PMC13432136

Genes

CYP2C19
SLCO1B1
ABCG2
CYP3A5
NUDT15
UGT1A1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomic landscape in Thailand: Array-based profiling and EMR-linked medication exposure.PMID 42545959Read ↗

Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population.Semantic proximity Read ↗

Genotype-predicted drug response phenotypes and their co-occurrence with dispensed medicines among 738,531 participants in the UK Our Future Health studySemantic proximity Read ↗

Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation.Semantic proximity Read ↗

Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse PopulationsSemantic proximity Read ↗

A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data.Semantic proximity Read ↗

Low-cost generation of clinical-grade, layperson-friendly pharmacogenetic passports using oligonucleotide arrays.Semantic proximity Read ↗

Pharmacogenomic landscape of the Thai population from genome sequencing of 949 individuals.Semantic proximity Read ↗

Evaluation of population-level pharmacogenetic actionability in Alabama.Semantic proximity Read ↗

Outcomes and Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management - A Cohort Study in 135 PatientsSemantic proximity Read ↗

Low-cost generation of clinical-grade layperson-friendly pharmacogenetic passports using oligonucleotide arraysSemantic proximity Read ↗

Frequency of pharmacogenomic variation and medication exposures among All of Us ParticipantsSemantic proximity Read ↗

Comparative evaluation of genotyping and low-pass sequencing for pharmacogenetic variant and phenotype inferenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.